IBJNews

Local software upstart sold after less than year in business

Back to TopCommentsE-mailPrintBookmark and Share

Indianapolis-based MyJibe LLC, an up-and-coming budgeting and personal finance software firm that was launched by two 20-something entrepreneurs last January, has already been acquired.

Provo, Utah-based MoneyDesktop, which also makes personal finance software, did not disclose how much it paid for MyJibe.

MyJibe co-founder Mike Langellier declined to elaborate on the terms of the deal, which closed last week and was announced Tuesday morning.

“It’s going to be very good for us and for the future of the business,” said Langellier, who created MyJibe with Brandon DeWitt. The pair met while working locally at Experian Information Solutions Inc. Langellier previously worked for Baker Hill, which Experian acquired in 2005.

Langellier and DeWitt plan to stay with the merged company, and MyJibe will maintain an office in the Indianapolis area, Langellier said.

MyJibe had just a handful of employees and was created with personal funds and support from Bloomington-based venture firm SproutBox.

“I was impressed with the potency of MyJibe’s team. They had accomplished what most of our well-funded competitors are still working toward,” MoneyDesktop’s CEO, Ryan Caldwell, said in a prepared statement.

MyJibe charges a monthly subscription fee of $7.99. It’s been touted as a more useful way for consumers not only to work out a savings strategy but also to plan what they need to spend ahead of time. The tool allows users to see how much discretionary money they have at any given moment.

It’s not clear how MoneyDesktop will incorporate MyJibe. MoneyDesktop, like MyJibe, also sells software to financial institutions for use by customers. MoneyDesktop said it has about 200 financial institution customers.

ADVERTISEMENT

  • Excellent example of a startup gone right
    Congrats to Mike and Brandon. A perfect example for other startups in Indy
  • Congrats
    Congratulations to the MyJibe team!

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. OK Larry, let's sign Lance, shore up the PG and let's get to the finals.

  2. A couple of issues need some clarification especially since my name was on the list. I am not sure how this information was obtained and from where. For me, the amount was incorrect to begin with and the money does not come to me personally. I am guessing that the names listed are the Principal Investigators (individual responsible for the conduct of the trail) for the different pharmaceutical trials and not the entity which receives the checks. In my case, I participate in Phase II and Phase III trials which are required for new drug development. Your article should differentiate the amount of money received for consulting, for speaking fees, and for conduct of a clinical trial for new drug development. The lumping of all of these categories may give the reader a false impression of physicians just trying to get rich. The Sunshine Law may help to differentiate these categories in the future. The public should be aware that the Clinical Trial Industry could be a real economic driver for Indiana since these revenues supports jobs and new job creation. Nationally, this account for 10-20 billion which our State is missing out on to a large degree. Yes, new drug and technology development has gotten most of the attention (e.g. CTSI, BioCrossroads, etc.) However, serious money is being left on the table by not participating in the clinical trials to get those new drugs and medical devices on the market!!!! I guess that this is not sexy enough for academia.

  3. The address given for the Goldfish Swim Club is the Ace Hardware, is it closing?

  4. Out of state management and ownership. If Kite controlled it, everything would be leased. Of course, due to the roundabout, there is limited access to the south side of 116th now also. Just have to go down to the light.

  5. Hey smudge, You're opposed to arresting people for minor crimes? Sounds great! We should only focus on murders and such, right? Let's stand around and wait until someone shoots someone before we act. Whatever we do, we should never question anyone, frisk anyone, or arrest anyone unless they are actively engaged in shooting or stabbing. Very sound!

ADVERTISEMENT